TR1 - Tier 1 doing a great job, but external factors slow it down.

Narratives are currently in beta

· The company's stock value has declined this week due to economic and political circumstances in Spain and Europe, particularly with the potential exit of France from the Euro. However, the company's strong fundamentals suggest it will continue on an upward trend, albeit at a slower pace. Currently, it presents a good opportunity for gradual investment, waiting to confirm whether the price continues to rise in the coming months.

· The "Create and Grow" Spanish law and the latest modifications to the anti-fraud Spanish laws have forced many companies to adapt their commercial dealing software to comply with these regulations. This situation gives Tier1 Technologies a commanding position against its peers.

· Tier1 unveiled its Strategic Plan for 2024-2026, focusing on enhancing its flagship product, Comerzzia, and implementing an ambitious strategy for stability and growth.

· The 2023 yearly results published show an increase of 19% in sales, reaching 21.82 million euros. The audited EBITDA has reached 3.15 million euros, an astonishing 66% increase compared to 2022. The solid balance sheet with high liquidity and low debt completes the picture. The net income was 1.71 million euros compared to 0.891 million euros a year ago.

How well do narratives help inform your perspective?

Disclaimer

The user A_Stricek holds no position in BME:TR1. Simply Wall St has no position in any of the companies mentioned. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.